title: Editorial commentary: dead or alive: can viability staining predict response to tuberculosis treatment?
authors.affiliation: Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine, Faculty of Health Sciences.
authors.forename: Stephen D
authors.initials: SD
authors.lastname: Lawn
authors.affiliation: Division of Medical Microbiology and Institute for Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa.
authors.forename: Mark P
authors.initials: MP
authors.lastname: Nicol
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D001431:Bacteriological Techniques / Q000379:methods*; D016903:Drug Monitoring / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D050296:Microbial Viability / Q000187:drug effects*; D008853:Microscopy / Q000379:methods*; D014376:Tuberculosis / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents
keywords: fluorescein diacetate; multidrug-resistant tuberculosis; treatment response; tuberculosis; viability stain